HEARTCARE-B (06609) Schedules 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Potential Final Dividend

Bulletin Express
Mar 16

Shanghai HeartCare Medical Technology Corporation Limited (HEARTCARE-B, 06609) has announced that its board of directors will convene on 26 March 2026. The agenda includes consideration and approval of the consolidated annual results for the financial year ended 31 December 2025 and deliberation on a potential final dividend proposal.

The notice, dated 16 March 2026, confirms that Chairman Wang Guohui will preside over the session. The current board comprises three executive directors (Wang Guohui, Zhang Kun, Wei Jiawei), three non-executive directors (Ding Kui, Chen Shaoxiong, Chen Gang) and three independent non-executive directors (Guo Shaomu, Feng Xiangqian, Gong Ping).

No additional financial figures or dividend amounts were disclosed in the announcement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10